Zhejiang Orient Gene Biotech Co.,Ltd. Posted 67.3 Million Yuan Net Loss in First Three Quarters of 2023

Zhejiang Orient Gene Biotech Co.,Ltd. (浙江东方基因生物制品股份有限公司) (688298.SH) reported a net loss of 67.3 million yuan in the first three quarters of 2023, reversing a net profit of 3.1 billion yuan for the same period in the previous year.

Meanwhile, the company posted 652.2 million yuan in revenue, down 91.7% year-on-year.

At the end of the reporting period, it had 9.2 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 13.6%.